Odyssey Health, Inc.

ODYYSEC EDGAR

Surgical & Medical Instruments & Apparatus(NV)CIK: 1626644

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	—	—	—	—	$0.00
Cost of Revenue	—	—	—	—	$0.00
Gross Profit	—	—	—	—	$0.00
Research and Development Expense	$55.2K	—	—	—	$20.2K
Operating Income (Loss)	-$2.1M	-$5.3M	-$8.1M	-$15.9M	-$3.8M
Interest Expense	—	—	$836.3K	$1.1M	$502.2K
Other Nonoperating Income (Expense)	$9.3K	$8.7K	—	—	—
Income Tax Expense (Benefit)

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$586.1K	$455.8K	$569.7K	$610.5K	$105.6K
Assets, Current	$56.9K	$405.9K	$526.4K	$610.1K	$99.6K
Cash and Cash Equivalents, at Carrying Value	—	—	$36.9K	$72.5K	$167.1K
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	—	—	—
Liabilities	—	—	—	—	$757.1K
Liabilities, Current	$5.9M	$6.6M	$5.2M	$3.4M	$707.1K
Long-term Debt	—	—	—	—	$50.0K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$1.2M	-$1.5M	-$3.2M	-$3.4M	-$649.1K
Net Cash Provided by (Used in) Investing Activities	$1.0M	-$10.1K	—	—	$0.00
Net Cash Provided by (Used in) Financing Activities	$180.7K	$1.4M	$2.7M	$3.9M	$545.0K
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)